Overview
Torsena is a European supplier of research-grade peptide blends dedicated to qualified laboratories and research institutions. This product contains CJC-1295 without DAC (Mod GRF 1-29) and Ipamorelin co-lyophilized in a single vial at equal ratio by weight. Orders ship from EU-based stock with batch documentation available upon request.
Lot & Supply Format
- Purity ≥99% each component, verified by HPLC/MS analysis
- Mannitol-free formulation (no bulking agents or buffers)
- Co-lyophilized blend in sealed glass research vials
- CoA transparency: batch-specific certificate of analysis available upon request
- Shipped from Europe with temperature-appropriate packaging
What is the CJC-1295 + Ipamorelin Blend?
This blend combines two of the most widely studied growth hormone axis research peptides within a single lyophilized preparation. CJC-1295 without DAC is a GHRH receptor agonist. Ipamorelin is a GHS-R1a agonist. The two peptides target complementary receptor systems that converge on pituitary somatotroph signaling.
CJC-1295 (no DAC) Component — GHRH receptor agonist. 29-amino acid modified GRF(1-29) with D-Ala2 and Gln8 substitutions. Acts through the adenylyl cyclase-cAMP-PKA signaling cascade.
Ipamorelin Component — GHS-R1a selective agonist. 5-amino acid pentapeptide. Acts through intracellular calcium mobilization and PKC signaling. Characterized as highly selective with minimal ACTH, cortisol, or prolactin pathway activation.
Published research describes synergistic amplification of GH-related signaling when GHRH and GHS receptor agonists are applied concurrently. The combined response exceeds the additive sum of either agonist alone. This synergistic relationship has made the CJC-1295 + Ipamorelin combination one of the most referenced pairings in growth hormone axis research.
Supplied exclusively for in-vitro and ex-vivo research by qualified laboratories. Not intended for human or animal administration.
Complementary Receptor Signaling
| Parameter | CJC-1295 (no DAC) | Ipamorelin |
|---|---|---|
| Target Receptor | GHRH-R | GHS-R1a |
| Signaling Cascade | cAMP-PKA | Ca²⁺-PKC |
| Peptide Length | 29 amino acids | 5 amino acids |
| Selectivity | GHRH-R specific | GHS-R1a selective |
| CAS Number | 863288-34-0 | 170851-70-4 |
Reconstitution & Storage
Lyophilized blend is stable at -20°C for long-term storage. Reconstitution for in-vitro work is typically performed using bacteriostatic water or sterile saline. Both components dissolve readily in standard reconstitution solutions. Reconstituted aliquots are generally stored at 2-8°C for short-term use. For extended storage, aliquot and freeze at -20°C to preserve peptide integrity. Avoid repeated freeze-thaw cycles. Researchers should follow institutional SOPs for handling lyophilized peptides.
Why Torsena
- Analytical Testing — Each component verified by third-party HPLC and mass spectrometry
- No Fillers — Mannitol-free, no bulking agents or buffer salts
- Batch Transparency — Certificate of Analysis available upon request
- EU Distribution — Shipped from European fulfillment with tracked courier
- Full Documentation — Batch-specific CoA and MSDS available for institutional procurement
Product Specifications
Product Name: CJC-1295 (no DAC) + Ipamorelin Research Blend
Composition: Equal ratio by weight (5mg + 5mg per 10mg vial)
CAS Numbers: 863288-34-0 / 170851-70-4
Purity: ≥99% each component (HPLC/MS)
Physical Form: White lyophilized powder
Additives: None (mannitol-free)
Intended Use: In-vitro / ex-vivo laboratory research only
Analytical Transparency
All Torsena research materials are tested for purity and identity by HPLC and mass spectrometry analysis. Batch-specific Certificates of Analysis are available upon request for institutional procurement.
- Reverse-phase HPLC purity determination (each component)
- Mass spectrometry identity confirmation (each component)
- Appearance and solubility verification
- Endotoxin screening (where applicable)
Related Research Compounds
Researchers studying growth hormone axis signaling, somatotroph receptor pharmacology, and metabolic pathways may also be interested in:
- Ipamorelin — standalone GHS-R1a selective agonist for growth hormone secretagogue research
- Retatrutide — triple GLP-1 / GIP / glucagon receptor agonist for metabolic research
- Tirzepatide — dual GLP-1 / GIP receptor agonist for metabolic research
Reviews
There are no reviews yet.